![Dani Stoltzfus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dani Stoltzfus
Corporate Officer/Principal at NEUBASE THERAPEUTICS, INC.
Dani Stoltzfus active positions
Companies | Position | Start | End |
---|---|---|---|
NEUBASE THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Career history of Dani Stoltzfus
Training of Dani Stoltzfus
Flinders University | Doctorate Degree |
Statistics
International
United States | 2 |
Australia | 2 |
Operational
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
NeuBase Therapeutics, Inc.
![]() NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Dani Stoltzfus
- Experience